Peripheral immunophenotype in dementia with Lewy bodies and Alzheimer's disease: an observational clinical study. Issue 11 (23rd September 2020)

• Record Type: Journal Article
• Authors: Amin, Jay; Boche, Delphine; Clough, Zoe; Teeling, Jessica; Williams, Anthony; Gao, Yifang; Chudley, Lindsey; Lau, Laurie; Smith, Florence; Harris, Scott; Holmes, Clive
• Is Part Of: Journal of neurology, neurosurgery and psychiatry. Volume 91:Issue 11(2020)
• Page Start: 1219
• Page End: 1226
• Publication Date: 2020-09-23
• Subjects: Neurology -- Periodicals; Nervous system -- Surgery -- Periodicals; Psychiatry -- Periodicals; 616.8
• DOI: 10.1136/jnnp-2020-323603
• Languages: English
• ISSNs: 0022-3050

Abstract

Abstract : Background: Inflammation plays a key role in the aetiology and progression of Alzheimer's disease (AD). However, the immunophenotype of the second most common neurodegenerative cause of dementia, dementia with Lewy bodies (DLB), remains unclear. To date there have been no studies examining peripheral inflammation in DLB using multiplex immunoassay and flow cytometry concomitantly. We hypothesised that, using blood biomarkers, DLB would show an increased proinflammatory profile compared with controls, and that there would be a distinct profile compared with AD. Methods: 93 participants (31 with DLB, 31 with AD and 31 healthy older controls) completed a single study visit for neuropsychiatric testing and phlebotomy. Peripheral blood mononuclear cells were quantified for T and B cell subsets using flow cytometry, and serum cytokine concentrations were measured using multiplex immunoassay. Results: We detected reduced relative numbers of helper T cells and reduced activation of B cells in DLB compared with AD. Additionally, interleukin (IL)-1β was detected more frequently in DLB and the serum concentration of IL-6 was increased compared with controls. Conclusions: Peripheral inflammation is altered in DLB compared with AD, with T cell subset analysis supporting a possible shift towards senescence of the adaptive immune system in DLB. Furthermore, there is a proinflammatory signature of serum cytokines in DLB. Identification of this unique peripheral immunophenotype in DLB could guide development of an immune-based biomarker and direct future work exploring potential immune modulation as a novel treatment.